JP2021534104A5 - - Google Patents

Info

Publication number
JP2021534104A5
JP2021534104A5 JP2021506660A JP2021506660A JP2021534104A5 JP 2021534104 A5 JP2021534104 A5 JP 2021534104A5 JP 2021506660 A JP2021506660 A JP 2021506660A JP 2021506660 A JP2021506660 A JP 2021506660A JP 2021534104 A5 JP2021534104 A5 JP 2021534104A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
independently selected
cycloalkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021506660A
Other languages
English (en)
Japanese (ja)
Other versions
JP7434281B2 (ja
JP2021534104A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/045459 external-priority patent/WO2020033514A1/en
Publication of JP2021534104A publication Critical patent/JP2021534104A/ja
Publication of JP2021534104A5 publication Critical patent/JP2021534104A5/ja
Application granted granted Critical
Publication of JP7434281B2 publication Critical patent/JP7434281B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021506660A 2018-08-08 2019-08-07 Pad酵素のベンズイミダゾール阻害剤 Active JP7434281B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862715845P 2018-08-08 2018-08-08
US62/715,845 2018-08-08
PCT/US2019/045459 WO2020033514A1 (en) 2018-08-08 2019-08-07 Benzimidazole inhibitors of pad enzymes

Publications (3)

Publication Number Publication Date
JP2021534104A JP2021534104A (ja) 2021-12-09
JP2021534104A5 true JP2021534104A5 (enExample) 2022-08-16
JP7434281B2 JP7434281B2 (ja) 2024-02-20

Family

ID=67766305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021506660A Active JP7434281B2 (ja) 2018-08-08 2019-08-07 Pad酵素のベンズイミダゾール阻害剤

Country Status (7)

Country Link
US (1) US20220348562A1 (enExample)
EP (1) EP3833439B1 (enExample)
JP (1) JP7434281B2 (enExample)
KR (1) KR20210042933A (enExample)
CN (1) CN112789087B (enExample)
ES (1) ES2956090T3 (enExample)
WO (1) WO2020033514A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7447080B2 (ja) 2018-08-08 2024-03-11 ブリストル-マイヤーズ スクイブ カンパニー Pad4阻害剤としての置換チエノピロール
MX2021001565A (es) 2018-08-08 2021-04-19 Bristol Myers Squibb Co Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad).
WO2021158840A1 (en) 2020-02-06 2021-08-12 Bristol-Myers Squibb Company Macrocyclic pad4 inhibitors useful as immunosuppressant
TW202140477A (zh) 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑
WO2021222353A1 (en) 2020-04-30 2021-11-04 Gilead Sciences, Inc. Macrocyclic inhibitors of peptidylarginine deiminases
TW202233174A (zh) 2020-12-22 2022-09-01 美商基利科學股份有限公司 肽基精胺酸去亞胺酶之抑制劑
WO2022140390A1 (en) 2020-12-22 2022-06-30 Gilead Sciences, Inc. Inhibitors of peptidylarginine deiminases
KR20260041867A (ko) 2023-07-21 2026-03-27 브리스톨-마이어스 스큅 컴퍼니 Pad4 조정제의 시트룰린화 및 활성을 평가하는 방법
WO2026020127A2 (en) 2024-07-19 2026-01-22 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad2 modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1214330A1 (en) * 1999-09-21 2002-06-19 LION Bioscience AG Benzimidazole derivatives and combinatorial libraries thereof
WO2010051245A1 (en) * 2008-11-03 2010-05-06 Merck Sharp & Dohme Corp. Benzimidazole and aza-benzimidazole carboxamides
KR101916443B1 (ko) * 2012-07-26 2018-11-08 글락소 그룹 리미티드 Pad4 억제제로서의 2-(아자인돌-2-일) 벤즈이미다졸
KR20180005250A (ko) * 2015-05-21 2018-01-15 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Pad4 억제제로서의 벤조이미다졸 유도체
AR107032A1 (es) * 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores bicíclicos de pad4
AR107030A1 (es) * 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores aza-bencimidazol de pad4
CA3015482A1 (en) * 2016-02-23 2017-08-31 Padlock Therapeutics, Inc. Heteroaryl inhibitors of pad4
WO2018022897A1 (en) * 2016-07-27 2018-02-01 Padlock Therapeutics, Inc. Covalent inhibitors of pad4
CN107311933B (zh) * 2017-06-28 2020-12-22 中国人民解放军军事医学科学院毒物药物研究所 一类苯并咪唑衍生物,及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2021534104A5 (enExample)
JP2021534108A5 (enExample)
JP2021534106A5 (enExample)
JP2021534097A5 (enExample)
JP2023512557A5 (enExample)
JP2023500611A5 (enExample)
RU2015122757A (ru) Бициклические соединения мочевины, тиомочевины, гуанидина и цианогуанидина, пригодные для лечения боли
JP2011079828A5 (enExample)
JP2021532109A5 (enExample)
RU2003101969A (ru) Новые соединения, обладающие антибактериальной, противогрибковой и противоопухолевой активностью
JP2011219498A5 (enExample)
JP2013504593A5 (enExample)
RU2001117757A (ru) Замещенные бензимидазолы и их применение в качестве ингибиторов поли(аденозиндифосфатрибоза)полимеразы
JP2012505235A5 (enExample)
JP2005538072A5 (enExample)
JP2011500685A5 (enExample)
CA2615022A1 (en) Hcv ns3 protease inhibitors
JP2011511095A5 (enExample)
JP2021514400A5 (enExample)
JP2014524441A5 (enExample)
JP2010504346A5 (enExample)
JP2018524403A5 (enExample)
JP2012508252A5 (enExample)
JP2009538897A5 (enExample)
JP2023526248A5 (enExample)